Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories, IRRUS Investments, HBAN Medtech Syndicate and Nextsteps Capital, the funding will...
PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced an expansion of their partnership with Pfizer. The parties will launch a new Antibody-Drug-Conjugate (ADC) collaboration while also expanding their existing $260M AI Lab collaboration, which itself was built upon a successful Generative Chemistry partnership.
The teams will leverage PostEra's AI platform, Proton,...
Iambic Therapeutics, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, announced that Michael Secora, Ph.D. will be its Chief Corporate Development Officer and Chief Financial Officer. Dr Secora will lead Iambic's finance and corporate development activities, helping frame its growing pipeline and industry-leading...
iBio, Inc., an AI-driven innovator of precision antibody immunotherapies, announced the expansion of its cardiometabolic and obesity treatment development program by in-licensing a potentially best-in-class long-acting anti-myostatin antibody from AstralBio, Inc. The antibody, now named IBIO-600, was identified by AstralBio using iBio’s proprietary technology stack and was designed for...
Partnership advances better neurovascular patient care by delivering timely insights to clinicians and improving clinical workflows
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, and Avicenna.AI, a leading provider of AI-based medical imaging solutions, announced that Viz.ai is integrating Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into the Viz.ai...
COTA Inc., a leader in real-world data and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. that will allow biopharmaceutical researchers to access the combined resources of COTA’s research-grade electronic health record (EHR) data from academic and community care centers and Guardant’s...
eClinical Solutions LLC, a global provider of digital clinical software and services, today announced a new collaboration with Snowflake, the AI Data Cloud Company, to establish a bidirectional integration that will enable life sciences organizations to address growing data challenges and unlock value with a modern clinical data architecture. As...
The Partnership Enables QuantHealth to Train its Simulation Models in Real-Time, and to Deploy its Simulation Models to Benefit Patients, Physicians, and Drug Developers
QuantHealth, an AI-powered drug development platform, announced its partnership with Atropos Health, a leader in translating clinical data into high-quality, personalized, real-world evidence for care. QuantHealth...
TetraScience, the Scientific Data and AI Cloud, announced it is teaming up with Snowflake to enable joint customers to unlock the value of their scientific data and reap the benefits of the Scientific AI revolution. The collaboration will allow the seamless sharing of scientific data between the Tetra Scientific...
Ingenuity Pathway Analysis Interpret extends analysis capabilities of human-curated knowledge base with AI technology.
QIAGEN announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.
Leveraging AI technology, IPA Interpret helps distill complex differential expression analyses into actionable...
